Abiomed Inc.

NASDAQ: ABMD · Real-Time Price · USD
381.02
0.00 (0.00%)
At close: Dec 21, 2022, 10:00 PM

Abiomed Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2022 FY 2021
Period Ending Mar 31, 2022 Mar 31, 2021
Net Income
136.5M 225.53M
Depreciation & Amortization
28.09M 24.1M
Stock-Based Compensation
52.73M 47.01M
Other Working Capital
-6.85M -10.49M
Other Non-Cash Items
95.85M -34.04M
Deferred Income Tax
2.41M 29.38M
Change in Working Capital
-30.2M -17.39M
Operating Cash Flow
285.39M 274.58M
Capital Expenditures
-35.76M -53.38M
Cash Acquisitions
-82.82M -52.18M
Purchase of Investments
-805.92M -582.3M
Sales Maturities Of Investments
543.51M 464.52M
Other Investing Acitivies
n/a n/a
Investing Cash Flow
-380.99M -223.34M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a -11.31M
Dividend Paid
n/a n/a
Other Financial Acitivies
-2.2M -8.07M
Financial Cash Flow
-2.2M -8.07M
Net Cash Flow
-99.89M 40.37M
Free Cash Flow
249.63M 221.19M